Pacific Biosciences of California, Inc. Gain (Loss) on Extinguishment of Debt
Pacific Biosciences of California, Inc. (PACB) reported Gain (Loss) on Extinguishment of Debt of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-02-25
- Pacific Biosciences of California, Inc. gain (loss) on extinguishment of debt for the quarter ending 2024-12-31 was $0.00.
- Pacific Biosciences of California, Inc. gain (loss) on extinguishment of debt for the quarter ending 2024-09-30 was $0.00.
- Pacific Biosciences of California, Inc. gain (loss) on extinguishment of debt for the quarter ending 2024-06-30 was $0.00.
- Pacific Biosciences of California, Inc. gain (loss) on extinguishment of debt for the quarter ending 2023-12-31 was $0.00.
- Pacific Biosciences of California, Inc. gain (loss) on extinguishment of debt for fiscal 2025 was $0.00.
- Pacific Biosciences of California, Inc. gain (loss) on extinguishment of debt for fiscal 2024 was $0.00.
- Pacific Biosciences of California, Inc. gain (loss) on extinguishment of debt for fiscal 2023 was -$2.03M.
- Pacific Biosciences of California, Inc. gain (loss) on extinguishment of debt for fiscal 2022 was $0.00.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-25 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | $0.00 10-K · filed 2026-02-25 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-09 | $0.00 10-Q · filed 2024-08-09 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | -$2.03M derived: sum of 3 quarters · filed 2026-02-25 | -$2.03M 10-K · filed 2026-02-25 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-12 | -$2.03M derived: sum of 2 quarters · filed 2024-11-12 | -$2.03M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | -$2.03M 10-Q · filed 2024-08-09 | -$2.03M 10-Q · filed 2024-08-09 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $0.00 derived: sum of 2 quarters · filed 2025-03-17 | $0.00 derived: sum of 3 quarters · filed 2025-03-17 | $0.00 10-K · filed 2025-03-17 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-03 | $0.00 derived: sum of 2 quarters · filed 2023-11-03 | $0.00 10-Q · filed 2023-11-03 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-04 | $0.00 10-Q · filed 2023-08-04 | ||
| 2021-12-31 | $0.00 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |